Literature DB >> 15165124

LPS-induced degeneration of dopaminergic neurons of substantia nigra in rats.

Gang Li1, Shenggang Sun, Xuebing Cao, Jiangxin Zhong, E'tang Tong.   

Abstract

In order to investigate the neurotoxicity of lipopolysaccharide (LPS) on the dopaminergic neurons of substantia nigra and the pathogenesis of Parkinson disease, LPS was stereotaxically infused into substantia nigra (SN). At different dosages and different time points with 5 microg LPS, the damage of the dopaminergic neurons in SN was observed by using tyrosine-hydroxylase (TH) immunohistochemical staining. The results showed that 14 days after injection of 0.1 microg to 10 microg LPS into the rat SN, TH-positive (TH+) neurons in the SN were decreased by 5%, 15%, 20%, 45 %, 96% and 99% respectively. After injection of 5 microg LPS, as compared with the control groups, TH+ neurons began to decrease at 3rd day and obviously decrease at 14th day, only 5% of total cells, and almost disappeared 30 days later. The results suggested that LPS could induce the degeneration of dopaminergic neurons in the SN in a dose- and time-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15165124     DOI: 10.1007/bf02830714

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  7 in total

1.  Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation.

Authors:  B Liu; L Du; J S Hong
Journal:  J Pharmacol Exp Ther       Date:  2000-05       Impact factor: 4.030

2.  Reply: a new look at the pathogenesis of Parkinson's disease

Authors: 
Journal:  Trends Pharmacol Sci       Date:  2000-05       Impact factor: 14.819

Review 3.  Morphological, biochemical and behavioural changes induced by neurotoxic and inflammatory insults to the nucleus basalis.

Authors:  F Casamenti; C Prosperi; C Scali; L Giovannelli; G Pepeu
Journal:  Int J Dev Neurosci       Date:  1998 Nov-Dec       Impact factor: 2.457

4.  Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats.

Authors:  L B Willard; B Hauss-Wegrzyniak; G L Wenk
Journal:  Neuroscience       Date:  1999-01       Impact factor: 3.590

5.  Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism.

Authors:  J Bas; M Calopa; M Mestre; D G Molleví; B Cutillas; S Ambrosio; E Buendia
Journal:  J Neuroimmunol       Date:  2001-02-01       Impact factor: 3.478

6.  Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures.

Authors:  D M Bronstein; I Perez-Otano; V Sun; S B Mullis Sawin; J Chan; G C Wu; P M Hudson; L Y Kong; J S Hong; M K McMillian
Journal:  Brain Res       Date:  1995-12-15       Impact factor: 3.252

7.  The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system.

Authors:  A J Herrera; A Castaño; J L Venero; J Cano; A Machado
Journal:  Neurobiol Dis       Date:  2000-08       Impact factor: 5.996

  7 in total
  8 in total

Review 1.  Impaired tissue barriers as potential therapeutic targets for Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  Xin Fang
Journal:  Metab Brain Dis       Date:  2018-04-22       Impact factor: 3.584

2.  Interaction between nonviral reprogrammed fibroblast stem cells and trophic factors for brain repair.

Authors:  G Liu; H Anisman; J Bobyn; S Hayley
Journal:  Mol Neurobiol       Date:  2014-03-28       Impact factor: 5.590

3.  Posttreatment with propofol attenuates lipopolysaccharide-induced up-regulation of inflammatory molecules in primary microglia.

Authors:  Mian Peng; Ji-Shi Ye; Yan-Lin Wang; Chang Chen; Cheng-Yao Wang
Journal:  Inflamm Res       Date:  2014-02-01       Impact factor: 4.575

4.  Protective effect of simvastatin on impaired intestine tight junction protein ZO-1 in a mouse model of Parkinson's disease.

Authors:  Xin Fang; Ren-Shi Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-12-16

5.  The endotoxin-induced neuroinflammation model of Parkinson's disease.

Authors:  Kemal Ugur Tufekci; Sermin Genc; Kursad Genc
Journal:  Parkinsons Dis       Date:  2011-01-18

6.  Chronic Systemic Inflammation Exacerbates Neurotoxicity in a Parkinson's Disease Model.

Authors:  Perla Ugalde-Muñiz; Ingrid Fetter-Pruneda; Luz Navarro; Esperanza García; Anahí Chavarría
Journal:  Oxid Med Cell Longev       Date:  2020-01-13       Impact factor: 6.543

7.  Effect of Ulinastatin on Early Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Surgery: A Systemic Review and Meta-Analysis.

Authors:  Mei Duan; Fangyan Liu; Huiqun Fu; Shuai Feng; Xue Wang; Tianlong Wang
Journal:  Front Neurosci       Date:  2021-06-21       Impact factor: 4.677

8.  Ulinastatin May Significantly Improve Postoperative Cognitive Function of Elderly Patients Undergoing Spinal Surgery by Reducing the Translocation of Lipopolysaccharide and Systemic Inflammation.

Authors:  Min Zhang; Yan-Hua Zhang; Hui-Qun Fu; Qing-Ming Zhang; Tian-Long Wang
Journal:  Front Pharmacol       Date:  2018-10-09       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.